FDA approves virtual reality rehab device for stroke, brain injury patients

The Food and Drug Administration on Wednesday approved MindMaze’s upper-limb rehabilitation platform, MindMotion Pro.

Advertisement

The neuro-technology platform uses 3-D motion tracking cameras, creating a virtual reality environment to aid stroke patients and individuals with other traumatic injuries.

The platform maps patients’ movements onto 3-D avatars and leads them through various rehabilitation exercises based on “standardized neurorehabilitation principles,” according to a news release.

Patients can use the platform as soon as four days post-stroke.

More articles on supply chain:

Viewpoint: Why healthcare needs more ‘me too’ drugs
Viewpoint: Pharma should give trial participants a say in pricing new drugs
Magellan vein-based blood tests underreported lead levels, says health officials

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.